drugset / Trial / NCT03528213
Utility of Sodium Lactate Infusion During Septic Shock
RandomizedParallel-groupOpen-labelTreatment
Summary
ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid balance in septic shock patients
Timeline
- Start
- 2019-10-04
- Primary completion
- 2023-02-21
- Completion
- 2023-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Lactate | Other / unclassified | 0.25 unknown | — |
| Subject | Sodium Lactate | Other / unclassified | 0.5 unknown | — |